drugset / Trial / NCT00848549

Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures

NCT00848549

Phase 3 Completed 295 enrolled Eisai Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the long-term safety and tolerability and to explore the long-term efficacy of zonisamide as monotherapy treatment in subjects with newly diagnosed partial seizures.

Timeline

Start
2008-10
Primary completion
2011-06
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carbamazepine Small molecule
Comparator Zonisamide Other / unclassified

Indications